MENA-SINO

Call Website Contact the organization

MENA-SINO Middle East North Africa of Stroke and Interventional Neurotherapies Organization MENA-SINO

In ICH, the first hour can shape the hours that follow. Blood-pressure control, ANNEXA-I and minimally invasive evacuati...
10/16/2026

In ICH, the first hour can shape the hours that follow. Blood-pressure control, ANNEXA-I and minimally invasive evacuation are changing how neurocritical teams think about speed, selection and escalation.

This session looks at the complete care pathway—not one intervention in isolation—and asks how to turn new evidence into coordinated action at the bedside. What would you change in your first-hour ICH protocol tomorrow?

Which trials will actually change what you do on Monday? This year’s stroke evidence is moving quickly, and the importan...
10/16/2026

Which trials will actually change what you do on Monday? This year’s stroke evidence is moving quickly, and the important question is not only what was published—but what should move into practice.

Trials Year in Review brings the key findings into one focused session so you can understand the signal, the limits and the practical consequence before the headlines become routine. Don’t wait for the journal summary. Which trial are you still trying to translate into workflow?

MeVO. Large-core stroke without perfusion. Two sides, one live vote—and an audience that has to take a position.This is ...
10/15/2026

MeVO. Large-core stroke without perfusion. Two sides, one live vote—and an audience that has to take a position.

This is debate as a clinical tool: evidence is tested in public, assumptions are exposed and the room decides where it stands. Come with your current view, then listen for the argument that could move it. What should guide the next major change in practice?

Six finalists. One stage. A new generation of MENA research ready to be seen.The Best Abstract and Young Investigator Aw...
10/15/2026

Six finalists. One stage. A new generation of MENA research ready to be seen.

The Best Abstract and Young Investigator Award brings fresh data, ambitious questions and the people who will shape the next era of neurovascular care into one room. Celebrate the work, follow the ideas and watch the next regional leaders make their case. Which research question deserves the spotlight next?

The Women in Neurointervention Network launches in Luxor with a clear purpose: connect, support and amplify women leadin...
10/15/2026

The Women in Neurointervention Network launches in Luxor with a clear purpose: connect, support and amplify women leading stroke and neurointervention across MENA.

This is more than a launch moment. It is a chance to build mentoring links, open collaboration and make regional expertise more visible. Help shape a network that is useful beyond the congress: who should be part of its next chapter, and what would make it valuable in your country?

Tandem occlusions. Wide-base basilar disease. Basilar plus ICAD. These are not textbook moments, and there is no hiding ...
10/14/2026

Tandem occlusions. Wide-base basilar disease. Basilar plus ICAD. These are not textbook moments, and there is no hiding behind a single algorithm when the case is live.

Case Theatre puts the decisions on stage: what to do first, when to change course and how experienced operators think under pressure. Expect real cases, real trade-offs and a room that sees the reasoning—not just the final answer. Which case would challenge your team most?

A stroke unit cannot improve what it does not measure. This systems lab focuses on the 10 metrics every MENA stroke serv...
10/14/2026

A stroke unit cannot improve what it does not measure. This systems lab focuses on the 10 metrics every MENA stroke service should be able to report—and, more importantly, act on.

The goal is practical: leave the room with a 90-day action plan for faster pathways, clearer accountability and better continuity of care. Bring your current numbers, your bottlenecks and the metric you wish you had. What will your first 90-day improvement target be?

The hyperacute chain is being rewritten. TNK is changing the thrombolysis conversation, while the 24-hour window and the...
10/14/2026

The hyperacute chain is being rewritten. TNK is changing the thrombolysis conversation, while the 24-hour window and the choice between bridging and direct-to-EVT continue to test every minute of the pathway.

This session connects the evidence to the handoffs that determine whether treatment is truly fast: recognition, imaging, transfer, thrombolysis and thrombectomy. Where does your chain lose the most time—and how will you fix it?

A global guideline is not automatically a practical guideline for every MENA hospital. Different resources, referral pat...
10/13/2026

A global guideline is not automatically a practical guideline for every MENA hospital. Different resources, referral pathways, staffing models and patient populations require solutions that work in the region—not only on paper.

In this session, the chapters are built live in Luxor: adapted, challenged and shaped around the realities of care across MENA. Bring the gap between recommendation and implementation. What should a truly regional guideline solve first?

Would you thrombectomise a large core on NCCT alone? This is not a question for a slide deck—it is a decision that chang...
10/13/2026

Would you thrombectomise a large core on NCCT alone? This is not a question for a slide deck—it is a decision that changes eligibility, speed and outcomes.

Expect a live vote, a live debate and a closer look at the patient-selection assumptions behind modern thrombectomy. Come ready to defend your criteria—and ready to change them when the evidence challenges you. How would your team vote?

Address

Los Angeles, CA

Alerts

Be the first to know and let us send you an email when MENA-SINO posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to MENA-SINO:

Share